Study of PDA-002 in Subjects With Peripheral Arterial Disease and Diabetic Foot Ulcers
Public ClinicalTrials.gov record NCT01859117. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1 Multicenter, Open-Label, Dose-Escalation Study to Evaluate the Safety and Efficacy of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Peripheral Arterial Disease and Diabetic Foot Ulcers
Study identification
- NCT ID
- NCT01859117
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Celularity Incorporated
- Industry
- Enrollment
- 15 participants
Conditions and interventions
Conditions
Interventions
- PDA-002 Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 22, 2013
- Primary completion
- Sep 30, 2016
- Completion
- Mar 13, 2017
- Last update posted
- Jun 3, 2026
2013 – 2017
United States locations
- U.S. sites
- 12
- U.S. states
- 9
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Carl T. Hayden Veterans Affairs Medical Center | Phoenix | Arizona | 85012 | — |
| UCLA | Los Angeles | California | 90095 | — |
| VA Palo Alto health | Palo Alto | California | 94304 | — |
| Dr. Wiliam M. Scholl College of Podiatric Medicine | North Chicago | Illinois | 60064 | — |
| Southern Illinois University School of Medicine | Springfield | Illinois | 62702 | — |
| Vascular Surgeon | Minneapolis | Minnesota | 55407 | — |
| University of North Carolina School of Medicine | Chapel Hill | North Carolina | 27599 | — |
| University of Oklahoma Health Sciences Center | Oklahoma City | Oklahoma | 73104 | — |
| Complete Family Foot Care - McAllen Office | McAllen | Texas | 78501-2930 | — |
| Endeavor Clinical Trials PA | San Antonio | Texas | 78229 | — |
| University of Virginia | Charlottesville | Virginia | 22908-0709 | — |
| University of Wisconsin | Madison | Wisconsin | 53792 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01859117, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 3, 2026 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01859117 live on ClinicalTrials.gov.